Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H38N.C2H3O2 |
Molecular Weight | 363.5771 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC([O-])=O.CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1
InChI
InChIKey=CBRUQZUHJAXNHS-UHFFFAOYSA-M
InChI=1S/C21H38N.C2H4O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-22-20-17-15-18-21-22;1-2(3)4/h15,17-18,20-21H,2-14,16,19H2,1H3;1H3,(H,3,4)/q+1;/p-1
Cetylpyridinium (used in a form of chloride salt) is a cationic surface-active agent and has a broad antimicrobial spectrum, with rapid killing of gram-positive pathogens and yeast in particular. It is suggested that interaction with bacteria occurs by the disruption of membrane function, leakage of cytoplasmic material, and ultimately the collapse of the intra-cellular equilibrium. The drug is used under various trade names as an oral OTC hygiene product (mouthwash, dental kits, etc.) to control the dental plaque and to prevent the subsequent gingivitis.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Bacterial membrane Sources: https://www.ncbi.nlm.nih.gov/pubmed/19138180 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | ANTISEPTIC (cetylpyridinium chloride) mouthwash Approved UseHelp to control plaque that leads to gingivitis. |
|||
Curative | ANTISEPTIC (cetylpyridinium chloride) mouthwash Approved UseHelp to control plaque that leads to gingivitis. |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
10 mg/g EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/16477395/ |
6 μL single, topical dose: 6 μL route of administration: Topical experiment type: SINGLE co-administered: |
CETYLPYRIDINIUM unknown | Mus musculus population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
127 mg × h/g EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/16477395/ |
6 μL single, topical dose: 6 μL route of administration: Topical experiment type: SINGLE co-administered: |
CETYLPYRIDINIUM unknown | Mus musculus population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
PubMed
Title | Date | PubMed |
---|---|---|
Efficacy of cetylpyridinium chloride used as oropharyngeal antiseptic. | 2001 |
|
The kinetics and thermodynamics of surfactants in solvent sublation. | 2001 Aug |
|
Effect of different chlorhexidine formulations in mouthrinses on de novo plaque formation. | 2001 Dec |
|
Morphology of three lyotropic liquid crystalline biological NMR media studied by translational diffusion anisotropy. | 2001 Dec 12 |
|
Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. | 2001 Dec 13 |
|
Hyaluronate receptors mediating glioma cell migration and proliferation. | 2001 Jun |
|
A novel pharmacological probe links the amiloride-insensitive NaCl, KCl, and NH(4)Cl chorda tympani taste responses. | 2001 Nov |
|
Passive immunization with milk produced from an immunized cow prevents oral recolonization by Streptococcus mutans. | 2001 Nov |
|
Gene expression by human articular chondrocytes cultured in alginate beads. | 2001 Oct |
|
PVC matrix membrane sensor for potentiometric determination of cetylpyridinium chloride. | 2001 Sep |
|
Effect of antimicrobial mouthrinses on the in vitro adhesion of Candida albicans to human buccal epithelial cells. | 2001 Sep |
|
Comparative evaluation of four decontamination protocols for the isolation of Mycobacterium avium subsp. paratuberculosis from milk. | 2001 Sep |
|
Adsorption of phenol and m-chlorophenol on organobentonites and repeated thermal regeneration. | 2002 |
|
Survival of Listeria monocytogenes in commercial food-processing equipment cleaning solutions and subsequent sensitivity to sanitizers and heat. | 2002 |
|
Development and validation of a photometric titration method for the quantitation of sodium chondroitin sulfate (bovine) in Cosequin DS chewable tablet. | 2002 Apr 15 |
|
Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. | 2002 Dec |
|
Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. | 2002 Jan 1 |
|
Differential effects of cadmium on proteoglycan synthesis of arterial smooth muscle cells: increase in small dermatan sulfate proteoglycans, biglycan and decorin, in the extracellular matrix at low cell density. | 2002 Jan 15 |
|
Time-resolved fluorometric analysis of carbohydrates labeled with amino-aromatic compounds by reductive amination. | 2002 Jul |
|
Interaction of cetylpyridine bromide with nucleic acids and determination of nucleic acids at nanogram levels based on the enhancement of resonance Rayleigh light scattering. | 2002 Jul |
|
Molecular cloning and characterization of human chondrolectin, a novel type I transmembrane protein homologous to C-type lectins. | 2002 Jul |
|
The effect of four mouthrinses on oral malodor. | 2002 Jun |
|
Cysteine challenge testing: a powerful tool for examining oral malodour processes and treatments in vivo. | 2002 Jun |
|
Liquid-liquid extraction of palladium(II) from hydrobromic acid media by hexadecylpyridinium bromide. | 2002 Mar |
|
Molecular alignment of denatured states of staphylococcal nuclease with strained polyacrylamide gels and surfactant liquid crystalline phases. | 2002 Mar 5 |
|
Utility of MTT assay in three-dimensional cultured human skin model as an alternative for draize skin irritation test: approach using diffusion law of irritant in skin and toxicokinetics-toxicodynamics correlation. | 2002 May |
|
Visible absorption spectra of the 4f electron transitions of neodymium, praseodymium, holmium and erbium complexes with fleroxacin and their analytical application. | 2002 May |
|
Buccoadhesive erodible disk for treatment of oro-dental infections: design and characterisation. | 2002 May 15 |
|
A mathematical model and mechanism of sublation of dye-surfactant ion complexes. | 2002 Nov |
|
Glycosaminoglycan blotting on nitrocellulose membranes treated with cetylpyridinium chloride after agarose-gel electrophoretic separation. | 2002 Sep |
|
Comparative evaluation of the MGIT and BACTEC culture systems for the recovery of Mycobacterium avium subsp. paratuberculosis from milk. | 2003 |
|
Clinical effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc-lactate on oral halitosis. A dual-center, double-blind placebo-controlled study. | 2003 Apr |
|
Combined effect of zinc ions and cationic antibacterial agents on intraoral volatile sulphur compounds (VSC). | 2003 Aug |
|
Examination of murine tear film. | 2003 Aug |
|
Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas. | 2003 Aug |
|
Dissolved organic matter effects on the performance of a barrier to polycyclic aromatic hydrocarbon transport by groundwater. | 2003 Feb |
|
A salivary incubation test for evaluation of oral malodor: a pilot study. | 2003 Jul |
|
Spectrophotometric method for the determination of manganese with phenylfluorone in the presence of Triton X-100 and cetylpyridinium chloride in pharmacological preparations and vegetable fertilizers. | 2003 Jul |
|
Purification of sulfated fucoglucuronomannan lyase from bacterial strain of Fucobacter marina and study of appropriate conditions for its enzyme digestion. | 2003 Jul-Aug |
|
Impact of brief exposure to balanced salts solution or cetylpyridinium chloride on the surface appearance of the rabbit corneal epithelium--a scanning electron microscopy study. | 2003 Jun |
|
Utility of formazans and cetylpyridinium chloride in rapid spectrophotometric determination of zinc in biological materials and pharmaceutical formulations. | 2003 Mar 10 |
|
Cooling towers--a potential environmental source of slow-growing mycobacterial species. | 2003 Mar-Apr |
|
Direct and specific recognition of glycosaminoglycans by antibodies after their separation by agarose gel electrophoresis and blotting on cetylpyridinium chloride-treated nitrocellulose membranes. | 2003 May |
|
The effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc lactate on the microflora of oral halitosis patients: a dual-centre, double-blind placebo-controlled study. | 2003 May |
|
Modification of ion chromatographic separations by ionic and nonionic surfactants. | 2003 May 16 |
|
[DNA complexes, formed on aqueous phase surfaces: new planar polymeric and composite nanostructures]. | 2003 Nov-Dec |
|
Reversible and irreversible adsorption of surfactants at a hanging mercury drop electrode. | 2003 Oct |
|
Inhibition of orally produced volatile sulfur compounds by zinc, chlorhexidine or cetylpyridinium chloride--effect of concentration. | 2003 Oct |
|
Soft antimicrobial agents: synthesis and activity of labile environmentally friendly long chain quaternary ammonium compounds. | 2003 Sep 11 |
|
Quenching of fluorescence of 1-hydroxypyrene-3,6,8-trisulfonate (HPTS) by Cu2+, Co2+, Ni2+, I-, and cetylpyridinium (CP+) ions in water/AOT/heptane microemulsion. | 2004 Mar 1 |
Sample Use Guides
Rinse for 30 seconds with 20 ml (4 teaspoonsfuls) twice a day, do not swallow.
Route of Administration:
Dental
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23039819
The panel of 24 laboratory strains including 18 oral bacteria, five nonoral bacterialspecies and the yeast Candida albicans was incubated with twofold serial dilutions of the 0.05% cetylpyridinium chloride mouthrinse for 48-72 h at 35 celsius degrees. For the agar dilution assays of cultivable plaque bacte-ria, the drug was added at a final concentration of 1%. MIC values were 1.5-3% for Aggregatibacter actinomycetemcomitans and Capnocytophaga gingivalis, 0.375% for Actinomyces meyeri, Moraxella catarrhalis, Campylobacter rectus, 0.187-0.375 % for Porphyromonas gingivalis, etc.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 15:09:26 GMT 2023 , Edited by admin on Fri Dec 15 15:09:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6W29RZ7YU2
Created by
admin on Fri Dec 15 15:09:26 GMT 2023 , Edited by admin on Fri Dec 15 15:09:26 GMT 2023
|
PRIMARY | |||
|
23921
Created by
admin on Fri Dec 15 15:09:26 GMT 2023 , Edited by admin on Fri Dec 15 15:09:26 GMT 2023
|
PRIMARY | |||
|
6W29RZ7YU2
Created by
admin on Fri Dec 15 15:09:26 GMT 2023 , Edited by admin on Fri Dec 15 15:09:26 GMT 2023
|
PRIMARY | |||
|
1307588
Created by
admin on Fri Dec 15 15:09:26 GMT 2023 , Edited by admin on Fri Dec 15 15:09:26 GMT 2023
|
PRIMARY | RxNorm | ||
|
C83616
Created by
admin on Fri Dec 15 15:09:26 GMT 2023 , Edited by admin on Fri Dec 15 15:09:26 GMT 2023
|
PRIMARY | |||
|
7439-73-8
Created by
admin on Fri Dec 15 15:09:26 GMT 2023 , Edited by admin on Fri Dec 15 15:09:26 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD